Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease
Tóm tắt
Congenital heart disease (CHD) affects a considerable number of children and adults worldwide. This implicates not only developmental disorders, high mortality, and reduced quality of life but also, high costs for the healthcare systems. CHD refers to a variety of heart and vascular malformations which could be very challenging to reconstruct the malformed region surgically, especially when the patient is an infant or a child. Advanced technology and research have offered a better mechanistic insight on the impact of CHD in the heart and vascular system of infants, children, and adults and identified potential therapeutic solutions. Many artificial materials and devices have been used for cardiovascular surgery. Surgeons and the medical industry created and evolved the ball valves to the carbon-based leaflet valves and introduced bioprosthesis as an alternative. However, with research further progressing, contracting tissue has been developed in laboratories and tissue engineering (TE) could represent a revolutionary answer for CHD surgery. Development of engineered tissue for cardiac and aortic reconstruction for developing bodies of infants and children can be very challenging. Nevertheless, using acellular scaffolds, allograft, xenografts, and autografts is already very common. Seeding of cells on surface and within scaffold is a key challenging factor for use of the above. The use of different types of stem cells has been investigated and proven to be suitable for tissue engineering. They are the most promising source of cells for heart reconstruction in a developing body, even for adults. Some stem cell types are more effective than others, with some disadvantages which may be eliminated in the future.
Từ khóa
Tài liệu tham khảo
AHA, 2018, Atrial Septal Defect (ASD)
Alessandri, 2004, Genetically engineered stem cell therapy for tissue regeneration, Annals of the New York Academy of Science, 1015, 271, 10.1196/annals.1302.023
Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964
Avolio, 2015, Stem cell therapy and tissue engineering for correction of congenital heart disease, Frontiers in Cell and Developmental Biology, 3, 1, 10.3389/fcell.2015.00039
Baffa, 2018, Tetralogy of fallot—pediatrics—MSD manual professional edition
Baheiraei, 2015, Electroactive polyurethane/siloxanederived from castor oil as a versatile cardiac patch, part I: synthesis, characterization, and myoblast proliferation anddifferentiation, Journal of Biomedical Materials Research Part A, 104, 775, 10.1002/jbm.a.35612
Baheiraei, 2016, Electroactive polyurethane/siloxanederived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations, Journal of Biomedical Materials Research Part A, 104, 1398, 10.1002/jbm.a.35669
Beltrami, 2003, Adult cardiac stem cells are multipotent and support myocardial regeneration, Cell, 114, 763, 10.1016/S0092-8674(03)00687-1
Boening, 2002, Long-term results after surgical correction of atrioventricular septal defects, European Journal of Cardio-Thoracic Surgery, 22, 167, 10.1016/S1010-7940(02)00272-5
Boheler, 2002, Differentiation of pluripotent embryonic stem cells into cardiomyocytes, Circulation Research, 91, 189, 10.1161/01.RES.0000027865.61704.32
Bonafè, 2014, Hyaluronan and cardiac regeneration, Journal of Biomedical Science, 21, 1, 10.1186/s12929-014-0100-4
Boroviak, 2014, The ability of inner cell mass cells to self-renew as embryonic stem cells is acquired upon epiblast specification, Nature Cell Biology, 16, 513, 10.1038/ncb2965
Bosman, 2011, Bioengineering and stem cell technology in the treatment of congenital heart disease, Circulation, 4, 768, 10.3390/jcm4040768
Bosman, 2015, Bioengineering and stem cell technology in the treatment of congenital heart disease, Journal of Clinical Medicine, 4, 768, 10.3390/jcm4040768
British Heart Foundation, 2016, Heart statistics
Brown, 2005, Cardiac extracellular matrix: a dynamic entity, AJP: Heart and Circulatory Physiology, 289, H973, 10.1152/ajpheart.00443.2005
Calderón-Colmenero, 2013, Congenital heart disease in Mexico, World Journal for Pediatric and Congenital Heart Surgery, 4, 165, 10.1177/2150135113477868
Camci-Unal, 2014, Hydrogels for cardiac tissue engineering, NPG Asia Materials, 6, e99, 10.1038/am.2014.19
Canadian Heart Alliance, 2018, Facts and issues
Caputo, 2015, MicroRNAs in vascular tissue engineering and post-ischemic neovascularization, Advanced Drug Delivery Reviews, 88, 78, 10.1016/j.addr.2015.05.003
Carminati, 2007, Transcatheter closure of congenital ventricular septal defects: results of the European Registry, European Heart Journal, 28, 2361, 10.1093/eurheartj/ehm314
Carrier, 1999, Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization, Biotechnology and Bioengineering, 5;64, 580, 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
Castilho, 2017, Melt electrospinning writing of poly-hydroxymethylglycolide-co- ε-caprolactone-based scaffolds for cardiac tissue engineering, Advanced Healthcare Materials, 6, 1, 10.1002/adhm.201700311
CDC, 2018, Congenital heart defects: atrial septal defect facts
CDC, 2018, Congenital heart defects: facts about hypoplastic left heart syndrome
Centola, 2010, Combining electrospinning and fused deposition modelling for the fabrication of a hybrid vascular graft, Biofabrication, 2, 1, 10.1088/1758-5082/2/1/014102
Chaikof, 2007, The development of prosthetic heart valve: lessons in form and function, The New England Journal of Medicine, 357, 1368, 10.1056/NEJMp078175
Chlupác, 2009, Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery, Physiological Research, 58, S119, 10.33549/physiolres.931918
Chopra, 2006, Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery, Journal of Pharmacy and Pharmacology, 58, 1021, 10.1211/jpp.58.8.0002
Cincinnati Children Health, 2018, Hirschsprung disease
Cleveland Clinic, 2018, Patent Ductus Arteriosus (PDA) treatment options
Cristallini, 2016, Micro- and macrostructured PLGA/Gelatin scaffolds promote early cardiogenic commitment of human mesenchymal stem cells in vitro, Stem Cells International, 2016, 1, 10.1155/2016/7176154
Dawson, 2011, Collagen scaffolds with or without the addition of RGD peptides support cardiomyogenesis after aggregation of mouse embryonic stem cells, In Vitro Cellular & Developmental Biology—Animal, 47, 653, 10.1007/s11626-011-9453-0
De Coppi, 2007, Isolation of amniotic stem cell lines with potential for therapy, Nature Biotechnology, 25, 100, 10.1038/nbt1274
Dodson, 2014, Comprehensive surgical management of congenital heart disease, 2
Dolk, 2011, Congenital heart defects in Europe: prevalence and perinatal mortality 2000–2005, Circulation, 123, 841, 10.1161/CIRCULATIONAHA.110.958405
Duan, 2011, Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors, Journal of Cardiovascular Translational Research, 4, 605, 10.1007/s12265-011-9304-0
Durant, 2018, The Ethiopian’s leg
Ebert, 2015, Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?, Molecular Medicine, 7, 1090, 10.15252/emmm.201504395
Fakoya, 2017, New delivery systems of stem cells for vascular regeneration in Ischemia, Frontiers in Cardiovascular Medicine, 4, 1, 10.3389/fcvm.2017.00007
Feric, 2016, Strategies and challenges to myocardial replacement therapy, Stem Cells Transplantation Medicine, 17, 410, 10.3390/ijms17060982
Fernandes, 2015, Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair, Stem Cell Reports, 5, 753, 10.1016/j.stemcr.2015.09.011
Files, 2012, ‘Shovel-Ready’ applications of stem cell advances for pediatric heart disease, Current Opinion In Pediatric, 24, 577, 10.1097/MOP.0b013e328357a4cf
Finch, 2011, The ancient origins of prosthetic medicine, The Lancet, 377, 548, 10.1016/S0140-6736(11)60190-6
Frederick, 2010, Stromal cell-derived factor-1 activation of tissue- engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis, Circulation, 122, S107, 10.1161/CIRCULATIONAHA.109.930404
Freeman, 2005, Spectrum of calcific aortic valve disease pathogenesis, disease progression, and treatment strategies, Circulation, 111, 3316, 10.1161/CIRCULATIONAHA.104.486738
Gil-Cayuela, 2016, New altered non-fibrillar collagens in human dilated cardiomyopathy: role in the remodeling process, PLOS ONE, 11, e0168130, 10.1371/journal.pone.0168130
Gilboa, 2016, Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010, Circulation, 134, 101, 10.1161/CIRCULATIONAHA.115.019307
Gott, 2003, Mechanical heart valves: 50 years of evolution, The Annals of Thoracic Surgery, 76, S2230, 10.1016/j.athoracsur.2003.09.002
Göv, 2016, Cardiomyogenic differentiation potential of human lipoaspirate-derivedstem cells on hyaluronic acid/gelatin plasma gels, Turkish Journal of Biology, 40, 369, 10.3906/biy-1504-7
Hashi, 2007, Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts, Proceedings of the National Academy of Sciences of the United States of America, 104, 11915, 10.1073/pnas.0704581104
HeartKids, 2018, Congenital heart disease
Hernández-Córdova, 2016, Indirect three-dimensional printing: a method for fabricating polyurethane-urea based cardiac scaffolds, Journal of Biomedical Materials Research Part A, 104, 1912, 10.1002/jbm.a.35721
Herpel, 2006, Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy, Histopathology, 48, 736, 10.1111/j.1365-2559.2006.02398.x
Hibino, 2010, Late- term results of tissue-engineered vascular grafts in humans, The Journal of Thoracic and Cardiovascular Surgery, 139, 431, 10.1016/j.jtcvs.2009.09.057
Hitscherich, 2016, The effect of PVDF-TrFE scaffolds on stem cell derived cardiovascular cells, Biotechnology and Bioengineering, 113, 1577, 10.1002/bit.25918
Hoffman, 2002, The incidence of congenital heart disease, Journal of the American College of Cardiology, 39, 1890, 10.16/S0735-1097(02)01886-7
Homann, 2000, Reconstruction of the RVOT with valved biological conduits: 25 years’ experience with allografts and xenografts, European Journal of Cardio-Thoracic Surgery, 17, 624, 10.1016/S1010-7940(00)00414-0
Hsieh, 2016, Prominent vascularization capacity of mesenchymal stem cells in collagen-gold nanocomposites, ACS Applied Materials & Interfaces, 8, 28982, 10.1021/acsami.6b09330
Ichihara, 2017, Epicardial placement of instantly produced fibrin glue- incorporating mesenchymal stromal cells for the treatment of heart failure, Circulation, 134
Ieda, 2010, Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors, Cell, 142, 375, 10.1016/j.cell.2010.07.002
Iop, 2009, The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds, Biomaterials, 30, 4104, 10.1016/j.biomaterials.2009.04.031
Johnson, 1998, An experimental model of small intestinal submucosa as a growing vascular graft, Journal of Thoracic and Cardiovascular Surgery, 116, 805, 10.1016/S0022-5223(98)00436-X
Kai, 2011, Polypyrrole-contained electrospun conductive nanofibrous membranes for cardiac tissue engineering, Journal of Biomedical Materials Research Part A, 99A, 376, 10.1002/jbm.a.33200
Kaiser, 2016, Physiological inspired cardiac scaffolds for tailored in vivo function and heart regeneration, Biomedical Materials, 10, 1, 10.1088/1748-6041/10/3/034003
Kane, 2014, Concise review: MicroRNAs as modulators of stem cells and angiogenesis, Stem Cell, 32, 1059, 10.1002/stem.1629
Karamichos, 2015, Ocular tissue engineering: current and future directions, Journal of Functioning Biomaterials, 6, 77, 10.3390/jfb6010077
Khan, 2018, Limited accuracy of administrative data for the identification and classification of adult congenital heart disease, Journal of the American Heart Association, 7, e007378, 10.1161/JAHA.117.007378
Krasuski, 2016, Congenital heart disease epidemiology in the United States, Circulation, 134, 110, 10.1161/CIRCULATIONAHA.116.023370
Kudová, 2016, HIF-1alpha deficiency attenuates the cardiomyogenesis of mouse embryonic stem cells, PLOS ONE, 11, e0158358, 10.1371/journal.pone.0158358
Kurobe, 2012, Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future, Stem Cells Translational Medicine, 1, 566, 10.5966/sctm.2012-0044
Landa, 2008, Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat, Circulation, 117, 1388, 10.1161/CIRCULATIONAHA.107.727420
Leor, 2009, Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine, Journal of the American College of Cardiology, 54, 1014, 10.1016/j.jacc.2009.06.010
Lewis, 2016, Will organs-in-a-dish ever replace animal models?
Li, 1999, Survival and function of bioengineered cardiac grafts, Circulation, 100, 1163
Llucià-Valldeperas, 2016, Electromechanical conditioning of adult progenitor cells improves recovery of cardiac function after myocardial infarction, Stem Cells Translational Medicine, 6, 970, 10.5966/sctm.2016-0079
Lu, 2013, Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells, Nature Communications, 4, 1, 10.1038/ncomms3307
Lundberg, 2013, Cardiovascular tissue engineering research support at the national heart, lung, and blood institute, Circulation Research, 112, 1097, 10.1161/CIRCRESAHA.112.300638
Lundy, 2013, Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells, Stem Cells and Development, 22, 1991, 10.1089/scd.2012.0490
Lüningschrör, 2013, MicroRNAs in pluripotency, reprogramming, and cell fate induction, Biochimicaet Biophysica Acta (BBA)—Molecular Cell Research, 1833, 1894, 10.1016/j.bbamcr.2013.03.025
Maeda, 2015, Matrix therapies for cell support and cardiac repair, 117
Mai, 2012, Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: featuring critical congenital heart defects targeted for pulse oximetry screening, Birth Defects Research Part A: Clinical and Molecular Teratology, 94, 970, 10.1002/bdra.23098
Makris, 2015, Repair and tissue engineering techniques for articular cartilage, Nature Reviews Reumatology, 11, 21, 10.1038/nrrheum.2014.157
Martins, 2018, Transposition of the great arteries
Masuda, 2008, Cell sheet engineering for heart tissue repair, Advanced Drug Delivery Reviews, 60, 277, 10.1016/j.addr.2007.08.031
Mayo Clinic, 2018, Atrial Septal Defect (ASD)
Mayo Clinic, 2018, Congenital heart disease in adults: bicuspid aortic valve
Mayo Clinic, 2018, Patent Ductus Arteriosus (PDA)
Mayo Clinic, 2018, Pulmonary valve stenosis
Mayo Clinic, 2018, Tetralogy of Fallot
Mayo Clinic, 2018, Tricuspid atresia
McCain, 2014, Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues, Biomaterials, 35, 5462, 10.1016/j.biomaterials.2014.03.052
Medscape, 2015, Pediatric valvar aortic stenosis
Menasché, 2014, Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience, European Heart Journal, 36, 743, 10.1093/eurheartj/ehu192
Menasché, 2015, Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report, European Heart Journal, 36, 2011, 10.1093/eurheartj/ehv189
Metcalfe, 2007, Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells, and regeneration, The Royal Society Interface, 4, 413, 10.1098/rsif.2006.0179
Minette, 2006, Ventricular septal defects, Circulation, 114, 2190, 10.1161/CIRCULATIONAHA.106.618124
Mirensky, 2010, Tissue-engineered vascular grafts: does cell seeding matter?, Journal of Pediatric Surgery, 45, 1299, 10.1016/j.jpedsurg.2010.02.102
Miyagawa, 2011, Tissue-engineered cardiac constructs for cardiac repair, The Annals of Thoracic Surgery, 91, 320, 10.1016/j.athoracsur.2010.09.080
Moreira, 2016, Tissue-engineered fibrin-based heart valve with bio-inspired textile reinforcement, Advanced Healthcare Materials, 5, 2113, 10.1002/adhm.201600300
Mukherjee, 2011, Evaluation of the biocompatibility of PLACL/Collagen nanostructured matrices with cardiomyocytes as a modelfor the regeneration of infarcted myocardium, Advanced Functional Materials, 21, 2291, 10.1002/adfm.201002434
Murohara, 2000, Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization, The Journal of Clinical Investigation, 105, 1527, 10.1172/JCI8296
London: National Institute for Cardiovascular Outcomes Research. https://www.ucl.ac.uk/nicor/audits/congenital/documents/annual-reports/National_Congenital_Heart_Disease_2013_16_annual_report
Navaei, 2016, Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs, Acta Biomaterialia, 41, 133, 10.1016/j.actbio.2016.05.027
Nayak, 2016, Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease, Cardiovascular Diagnosis and Therapy, 6, 44, 10.3978/j.issn.2223-3652.2015.12.01
Nelson, 2011, Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges, Acta Biomaterialia, 7, 1, 10.1016/j.actbio.2010.06.039
NHS, 2018, Symptoms: congenital heart disease
NHS England, 2015, Proposed national standards and service specifications for congenital heart disease services: financial impact analysis
Nie, 2010, Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model, Journal of Zhejiang University Science B, 11, 895, 10.1631/jzus.B1000302
NIH, 2018, Hirschsprung disease
Northwestern Medicine, 2018, Symptoms of bicuspid aortic valve
Okada, 1995, Role of Endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension, Circulation, 92, 114, 10.1161/01.CIR.92.1.114
Okudo, 2001, Intravascular and intracardiac stents used in congenital heart disease, Current Opinions in Cardiology, 16, 84, 10.1097/00001573-200103000-00002
Olausson, 2014, In vivo application of tissue-engineered veins using autologous peripheral whole blood: a proof of concept study, EBioMedicine, 1, 72, 10.1016/j.ebiom.2014.09.001
Patnana, 2018, Pediatric hypoplastic left heart syndrome
Pedra, 2009, Paediatric and congenital heart disease in South America: an overview, Heart, 95, 1385, 10.1136/hrt.2008.152017
Perry, 2003, Bone marrow as a cell source for tissue engineering heart valves, The Annals of Thoracic Surgery, 75, 761, 10.1016/S0003-4975(02)03776-1
Petsche Connell, 2013, Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications, Tissue Engineering, 19, 368, 10.1089/ten.TEB.2012.0561
Pok, 2013, A multi-layered scaffold of a chitosan and gelatinhydrogel supported by a PCL core for cardiac tissue engineering, Acta Biomater, 9, 5630, 10.1016/j.actbio.2012.10.032
Postoev, 2014, Epidemiology of cardiovascular malformations among newborns in Monchegorsk (north-west Russia): a register-based study, Journal of Public Health Research, 3, 76, 10.4081/jphr.2014.270
Quarti, 2011, Preliminary experience in the use of an extracellular matrix to repair congenital heart diseases, Interactive CardioVascular and Thoracic Surgery, 13, 569, 10.1510/icvts.2011.280016
Ratner, 2004, Biomaterials science, 2
Rienks, 2014, Myocardial extracellular matrix: an ever-changing and diverse entity, Circulation Research, 114, 872, 10.1161/CIRCRESAHA.114.302533
Ruiz, 2005, Transcatheter placement of a low-profile 4biodegradable pulmonary valve made of small intestinal submucosa: a long-term study in a swine model, Journal of Thoracic and Cardiovascular Surgery, 130, 477, 10.1016/j.jtcvs.2005.04.008
Rupp, 2015, Cardiac regeneration in children, Pediatric Cardiology, 36, 713, 10.1007/s00246-015-1120-x
Sabbah, 2013, Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure, JACC: Heart Failure, 1, 252, 10.1016/j.jchf.2013.02.006
Safi, 2016, Current management of Ebstein’s anomaly in the adult, Current Treatment Options in Cardiovascular Medicine, 18, 56, 10.1007/s11936-016-0478-2
Sakai, 2001, The fate of a tissue- engineered cardiac graft in the right ventricular outflow tract of the rat, Journal of Thoracic and Cardiovascular Surgery, 121, 932, 10.1067/mtc.2001.113600
Sales, 2011, Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves, Tissue Engineering, 16, 257, 10.1089/ten.TEA.2009.0424
Saxena, 2010, Congenital anomalies of soft tissues: birth defects depending on tissue engineering solutions and present advances in regenerative medicine, Tissue Engineering, 16, 455, 10.1089/ten.TEB.2009.0700
Schmidt, 2007, Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source, Circulation, 11;116, I64
Schmidt, 2010, Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering, Biomaterials, 21, 2215, 10.1016/S0142-9612(00)00148-4
Schmidt, 2004, Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts, The Annal of Thoracic Surgery, 78, 2094, 10.1016/j.athoracsur.2004.06.052
Schmidt, 2006, Living autologous heart valves engineered from human prenatally harvested progenitors, Circulation, 114, I125
Scholl, 2010, Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease, World Journal of Pediatric and Congenital Heart Surgery, 1, 132, 10.1177/2150135110362092
Serpooshan, 2016, The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction, Biomaterials, 34, 9048, 10.1016/j.biomaterials.2013.08.017
Sharifpanah, 2017, Embryonic stem cells for tissue biocompatibility, angiogenesis, and inflammation testing, Cells Tissues Organs, 204, 1, 10.1159/000471794
Skybchyk, 2017, Calcific aortic valve stenosis: current approaches to the diagnosis, medical and surgical treatment, Hypertension, 0(6.50), 74, 10.22141/2224-1485.6.50.2016.89777
Smith, 2015, MicroRNAs in congenital heart disease, Annals of Translational Medicine, 21, 1, 10.3978/j.issn.2305-5839.2015.12.25
Spicer, 2014, Ventricular septal defect, Orphanet Journal of Rare Diseases, 9, 1, 10.1186/1750-1172-9-1
Su, 2016, Exceptionalbiocompatibility of 3D fibrous scaffold for cardiac tissueengineering fabricated from biodegradable polyurethane blended withcellulose, International Journal of Polymeric Materials and Polymeric Biomaterials, 65, 703, 10.1080/00914037.2016.1157802
Sugiura, 2016, Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model, Journal of Cardiothoracic Surgery, 11, 1, 10.1186/s13019-016-0559-z
Sugiura, 2018, Tissue-engineered vascular in children with congenital heart disease: intermediate term followup, Seminars in Thoracic and Cardiovascular Surgery, 30, 175, 10.1053/j.semtcvs.2018.02.002
Sun, 2015, Congenital heart disease: causes, diagnosis, symptoms, and treatments, Cell Biochemistry and Biophysics, 72, 857, 10.1007/s12013-015-0551-6
Sun, 2017, Carbon nanotube- incorporated collagen hydrogels improve cell alignment and the performance of cardiac constructs, International Journal of Nanomedicine, 12, 3109, 10.2147/IJN.S128030
Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019
Takehara, 2008, Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction, Journal of the American College of Cardiology, 52, 1858, 10.1016/j.jacc.2008.06.052
Tao, 2014, Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel, Journal of Tissue Engineering and Regenerative Medicine, 11, 153, 10.1002/term.1895
Tarui, 2014, Stem cell therapies in patients with single ventricle physiology, Methodist Debakey Cardiovascular Journal, 10, 77, 10.14797/mdcj-10-2-77
Terrovitis, 2009, Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery, Journal of the American College of Cardiology, 54, 1619, 10.1016/j.jacc.2009.04.097
Tomecka, 2017, Poly(l-lactic acid) and polyurethane nanofibers fabricated by solution blow spinning as potential substrates for cardiac cell culture, Materials Science and Engineering: C, 75, 305, 10.1016/j.msec.2017.02.055
Torok, 2015, Coarctation of the aorta: management from infancy to adulthood, World Journal of Cardiology, 7, 765, 10.4330/wjc.v7.i11.765
Van der Linde, 2011, Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis, Journal of the American College of Cardiology, 58, 2241, 10.16/j.jacc.2011.08.025
Vicinanza, 2017, Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification, Cell Death and Differentiation, 24, 2101, 10.1038/cdd.2017.130
Vincentelli, 2007, In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?, Surgery, 134, 424, 10.1016/j.jtcvs.2007.05.005
Wainwright, 2012, Right ventricular outflow tract repair with a cardiac biologic scaffold, Cells Tissues Organs, 195, 159, 10.1159/000331400
Wang, 2014, Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction, Biomaterials, 35, 3986, 10.1016/j.biomaterials.2014.01.021
Wang, 2012, Design and fabrication of a biodegradable, covalently crosslinked shape-memory alginate scaffold for cell and growth factor delivery, Tissue Engineering Part A, 18, 2000, 10.1089/ten.tea.2011.0663
Webera, 2011, Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth, Placenta, 32, S316, 10.1016/j.placenta.2011.04.001
Williams, 2004, Benefit and risk in tissue engineering, Materials Today, 7, 24, 10.1016/S1369-7021(04)00232-9
Witt, 2013, Short-term experience of porcine small intestinal submucosa patches in paediatric cardiovascular surgery, European Journal of Cardiothoracic Surgery, 44, 72, 10.1093/ejcts/ezs638
Yacoub, 2013, CADUCEUS, SCIPIO, ALCADIA: cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving, Global Cardiology Science and Practice, 3, 6, 10.5339/gcsp.2013.3
Yang, 2010, The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin—hyaluronic acid cardiac patches, Biomaterials, 31, 854, 10.1016/j.biomaterials.2009.09.096
Yao, 2016, Combination of endothelial progenitor cells, extracellular matrix and aligned eletrospun polyhydroxyalkanoate scaffold for vascular tissue engineering, Cytotherapy, 18, 10.1016/j.jcyt.2016.03.149
Yoon, 2009, Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 91B, 163, 10.1002/jbm.b.31386
Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526
Yu, 2017, Mechanically and electrically enhanced CNT—collagen hydrogels as potential scaffolds for engineered cardiac constructs, ACS Biomaterials Science & Engineering, 3, 3017, 10.1021/acsbiomaterials.6b0062
Zhao, 2015, Recent advances in electrospun nanofibrous scaffolds for cardiac tissue engineering, Advanced Functional Materials, 9, 5726, 10.3390/ma9080614
Zhou, 2012, Tissue engineering of small-diameter vascular grafts by endothelial progenitor cells seeding heparin-coated decellularized scaffolds, Journal of Biomedical Materials Research, 100, 111, 10.1002/jbm.b.31928
Zilla, 2008, Prosthetic heart valves: catering for the few, Biomaterials, 29, 385, 10.1016/j.biomaterials.2007.09.033
Zimmermann, 2004, Engineered heart tissue for regeneration of diseased hearts, Biomaterials, 25, 1639, 10.1016/S0142-9612(03)00521-0
Zisch, 2004, Tissue engineering of angiogenesis with autologous endothelial progenitor cells, Current Opinion in Biotechnology, 15, 424, 10.1016/j.copbio.2004.08.005